What is the CVR number of Nordic Stem Cell Clinic ApS?

Nordic Stem Cell Clinic ApS is registered with CVR / Virk under CVR 44048434.

What is the revenue of Nordic Stem Cell Clinic ApS?

Nordic Stem Cell Clinic ApS reported revenue of DKK -265K in 2024.

Who is the CEO of Nordic Stem Cell Clinic ApS?

Søren Paludan Sheikh is Chief Executive Officer of Nordic Stem Cell Clinic ApS, in role since 2023.

Where is Nordic Stem Cell Clinic ApS headquartered?

Nordic Stem Cell Clinic ApS's registered address is Ole Maaløes Vej 3, 3..

Nordic Stem Cell Clinic ApS

APSActive

CVR 44048434Ole Maaløes Vej 3, 3.Research and experimental development on natural sciences and engineering · NACE 7210Est. 2023— employees

Full Risika report

Revenue 2024

DKK -265K

+36212% vs 2023

EBITDA margin

100.0%

-36212% vs 2023

Equity ratio

19.2%

Financial strength

Net profit 2024

DKK -265K

-2154% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -265K	+36212%
EBITDA	DKK -265K	-36212%
Net profit	DKK -265K	-2154%
Total assets	DKK 4,4M	+22%
Equity	DKK 839K	-24%
Employees	—	—

Item	2023	2024
Revenue	-1	-265
Staff expenses	-0	-0
EBITDA	-1	-265
Depreciation & amort.	-0	-0
EBIT	-1	-265
Net financials	-11	0
Profit before tax	-12	-265
Tax	-0	-0
Net profit	-12	-265

Item	2023	2024
Total assets	3.587	4.376
Equity	1.103	839
Long-term debt	0	0
Short-term debt	2.484	3.537
Total debt	2.484	3.537

Name	Role	Member since	Age	Other directorships
SP Søren Paludan Sheikh Chief Executive Officer	Chief Executive Officer	2023	—	—

Shareholder	Type	Ownership	Votes	Since
SPSheikh Holding ApS	Company	33.3%	33.3%	2023
ANDRÉ ROGACZEWSKI HOLDING II ApS	Company	25.0%	33.3%	2023
Ulveman Invest ApS	Company	5.0%	5.0%	2023

Person	Role here	Other companies
Søren Paludan Sheikh	Chief Executive Officer	0 companies

Nordic Stem Cell Clinic ApS

APSActive

CVR 44048434Ole Maaløes Vej 3, 3.Research and experimental development on natural sciences and engineering · NACE 7210Est. 2023— employees

Full Risika report

Revenue 2024

DKK -265K

+36212% vs 2023

EBITDA margin

100.0%

-36212% vs 2023

Equity ratio

19.2%

Financial strength

Net profit 2024

DKK -265K

-2154% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -265K	+36212%
EBITDA	DKK -265K	-36212%
Net profit	DKK -265K	-2154%
Total assets	DKK 4,4M	+22%
Equity	DKK 839K	-24%
Employees	—	—